Teladoc Health/$TDOC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Teladoc Health
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
- Ticker
- $TDOC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 5,124
- Headquarters
- New York, United States
- Website
- www.teladochealth.com
Teladoc Health Metrics
BasicAdvanced
$1.6B
-
-$0.86
2.14
-
Price and volume
Market cap
$1.6B
Beta
2.14
52-week high
$9.89
52-week low
$4.40
Average daily volume
4.3M
Financial strength
Current ratio
0.866
Quick ratio
0.764
Long term debt to equity
0.022
Total debt to equity
0.792
Interest coverage (TTM)
-6.50%
Profitability
EBITDA (TTM)
68.566
Gross margin (TTM)
68.57%
Net profit margin (TTM)
-6.27%
Operating margin (TTM)
-5.36%
Effective tax rate (TTM)
2.41%
Revenue per employee (TTM)
$480,000
Management effectiveness
Return on assets (TTM)
-2.93%
Return on equity (TTM)
-11.52%
Valuation
Price to revenue (TTM)
0.637
Price to book
1.23
Price to tangible book (TTM)
-15.07
Price to free cash flow (TTM)
12.458
Free cash flow yield (TTM)
8.03%
Free cash flow per share (TTM)
0.701
Growth
Revenue change (TTM)
-2.38%
Earnings per share change (TTM)
-32.69%
3-year revenue growth (CAGR)
-1.46%
10-year revenue growth (CAGR)
36.69%
3-year earnings per share growth (CAGR)
-67.24%
10-year earnings per share growth (CAGR)
-7.38%
What the Analysts think about Teladoc Health
Analyst ratings (Buy, Hold, Sell) for Teladoc Health stock.
Analyst projections of the future price of Teladoc Health stock.
Bulls say / Bears say
Third-quarter adjusted EBITDA rose 14% and the net loss narrowed, while Teladoc raised its full-year revenue and adjusted EBITDA guidance. That points to better cost control even as sales remain under pressure. (Teladoc Health)
BetterHelp’s insurance-covered revenue climbed to $32.1 million from $3.7 million a year earlier, and management reported an annualised run rate of about $140 million. If therapist capacity and insurance uptake keep growing, that channel could offset some of the cash-pay decline over time. (Teladoc Health, The Motley Fool)
Teladoc One is moving into early client launches, with broader availability planned for January 2027. Its coordinated care teams and AI support could give the company a new way to deepen engagement and grow its Integrated Care offering. (Teladoc Health, Teladoc Health)
BetterHelp remains a major drag: third-quarter revenue fell 13%, consumer and other revenue dropped 25%, and paying users declined 12%. Management still expects the segment’s revenue to fall 13% to 16% for 2026. (Teladoc Health)
Integrated Care is growing only slowly: third-quarter revenue rose 2%, while US membership fell 2% and access-fee revenue fell 10%. This leaves little evidence yet that the largest segment can deliver strong, broad-based growth. (Teladoc Health)
Teladoc remains loss-making, and free cash flow for the first nine months fell to $85.4 million from $113.5 million a year earlier. The weaker year-to-date cash generation leaves less room for error if the business turnaround takes longer than planned. (Teladoc Health)
Data summarised monthly by Lightyear AI. Last updated on 29 Oct 2026.
Teladoc Health Financial Performance
Revenues and expenses
Teladoc Health Earnings Performance
Company profitability
Upcoming events
No upcoming events
Teladoc Health News
AllArticlesVideos
Funds containing Teladoc Health
Fund name | Fund size | $TDOC weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.14% |
iShares Ageing Population£AGES | $953M | 0.14% |
iShares Ageing Population€AGED | $903M | 0.14% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.05% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.